The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 24613701 |
6 |
Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression. |
Norwegian Medical Cyclotron Centre |
| 14971889 |
50 |
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues. |
Abbott Laboratories |
| 2552116 |
37 |
Active reduced-size hexapeptide analogues of luteinizing hormone-releasing hormone. |
Abbott Laboratories |
| 16789738 |
61 |
Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists. |
Takeda Pharmaceutical |
| 14971906 |
74 |
Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonists. |
Neurocrine Biosciences |
| 12502365 |
41 |
Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor. |
Takeda Chemical Industries |
| 9784092 |
15 |
Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor. |
Takeda Chemical Industries |
| 21657270 |
61 |
Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor. |
Takeda Pharmaceutical |
| 20236823 |
41 |
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptor. |
Wyeth Research |
| 19271735 |
35 |
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R). |
Wyeth Research |
| 19251413 |
64 |
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template. |
Wyeth Research |
| 19006286 |
37 |
Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor. |
Neurocrine Biosciences |
| 18511284 |
64 |
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. |
Wyeth Research |
| 18419112 |
63 |
Non-peptide gonadotropin-releasing hormone receptor antagonists. |
Neurocrine Biosciences |
| 17937987 |
83 |
Synthesis and structure-activity relationships of thieno[2,3-b]pyrroles as antagonists of the GnRH receptor. |
Astrazeneca |
| 17521908 |
66 |
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonists. |
Neurocrine Biosciences |
| 17402723 |
30 |
Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives. |
Salk Institute |
| 16722655 |
28 |
Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist. |
Pfizer |
| 15951171 |
39 |
Structure-activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists. |
Neurocrine Biosciences |
| 15837306 |
92 |
Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives. |
Kyoto 619-0216 |
| 15715483 |
88 |
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization. |
Neurocrine Biosciences |
| 15664861 |
44 |
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides. |
Kyoto 619-0216 |
| 15664860 |
44 |
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamides. |
Kyoto 619-0216 |
| 15214774 |
28 |
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptor. |
Neurocrine Biosciences |
| 15026074 |
16 |
Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists. |
Merck |
| 14505682 |
29 |
Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists. |
Neurocrine Biosciences |
| 12954050 |
2 |
Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues. |
Institute of Science |
| 12951117 |
31 |
Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH Receptor. |
Neurocrine Biosciences |
| 12951116 |
30 |
Synthesis and structure-activity relationships of 1-arylmethyl-3-(2-aminopropyl)-5-aryl-6-methyluracils as potent GnRH receptor antagonists. |
Neurocrine Biosciences |
| 12443792 |
51 |
Characterization of mono- and diaminopyrimidine derivatives as novel, nonpeptide gonadotropin releasing hormone (GnRH) receptor antagonists. |
Agouron Pharmaceuticals |
| 12419385 |
48 |
The discovery of novel small molecule non-peptide gonadotropin releasing hormone (GnRH) receptor antagonists. |
Agouron Pharmaceuticals |
| 12127532 |
22 |
Synthesis and initial structure-activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists. |
Neurocrine Biosciences |
| 11814806 |
39 |
Initial structure-activity relationship studies of a novel series of pyrrolo[1,2-a]pyrimid-7-ones as GnRH receptor antagonists. |
Neurocrine Biosciences |
| 11606129 |
4 |
Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone. |
Institute of Science |
| 11425547 |
137 |
Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus. |
Merck Research Laboratories |
| 11425546 |
89 |
Substituted indole-5-carboxamides and -acetamides as potent nonpeptide GnRH receptor antagonists. |
Merck Research Laboratories |
| 11327594 |
26 |
Heterocyclic derivatives of 2-(3,5-dimethylphenyl)tryptamine as GnRH receptor antagonists. |
Merck Research Laboratories |
| 11327593 |
16 |
2-(3,5-Dimethylphenyl)tryptamine derivatives that bind to the GnRH receptor. |
Merck Research Laboratories |
| 11300873 |
8 |
A potent, nonpeptidyl 1H-quinolone antagonist for the gonadotropin-releasing hormone receptor. |
Merck Research Laboratories |
| 11229760 |
20 |
SAR studies of novel 5-substituted 2-arylindoles as nonpeptidyl GnRH receptor antagonists. |
Merck Research Laboratories |
| 11229759 |
40 |
Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles. |
Merck Research Laboratories |
| 10956191 |
31 |
Design and synthesis of potent hexapeptide and heptapeptide gonadotropin-releasing hormone antagonists by truncation of a decapeptide analogue sequence. |
Institute of Science |
| 10956190 |
11 |
Structure-activity studies of reduced-size gonadotropin-releasing hormone agonists derived from the sequence of an endothelin antagonist. |
Institute of Science |
| 10937733 |
70 |
Quinolones as gonadotropin releasing hormone (GnRH) antagonists: simultaneous optimization of the C(3)-aryl and C(6)-substituents. |
Merck Research Laboratories |
| 27608177 |
202 |
Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist. |
Sk Chemicals |
| 10743944 |
68 |
Potent antagonists of gonadotropin releasing hormone receptors derived from quinolone-6-carboxamides. |
Merck Research Laboratories |
| 10715149 |
46 |
Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists. |
Salk Institute |
| 10715148 |
27 |
Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists. |
Salk Institute |
| 10715147 |
41 |
Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists. |
Salk Institute |
| 10498221 |
11 |
Investigation of the 4-O-alkylamine substituent of non-peptide quinolone GnRH receptor antagonists. |
Merck Research Laboratories |
| 10498220 |
22 |
Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist. |
Merck Research Laboratories |
| 9371239 |
43 |
Betidamino acid scan of the GnRH antagonist acyline. |
Salk Institute |
| 7510341 |
51 |
In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone. |
Tap Pharmaceuticals |
| 8385226 |
7 |
The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists. |
Abbott Laboratories |
| 3279211 |
16 |
Design of potent cyclic gonadotropin releasing hormone antagonists. |
Salk Institute |
| 2549244 |
13 |
LH-RH antagonists: design and synthesis of a novel series of peptidomimetics. |
Abbott Laboratories |
| 29335207 |
52 |
Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists. |
Tiumbio |
| 1714956 |
17 |
Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties. |
Salk Institute |
Search and Browse
